Angiotensin receptor blockade not related to history of dry eye symptoms and treatment in The Diabetic Retinopathy Candesartan Trials (DIRECT)

Acta Ophthalmol. 2011 Sep;89(6):e535-6. doi: 10.1111/j.1755-3768.2010.01992.x. Epub 2010 Aug 31.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use*
  • Benzimidazoles / therapeutic use*
  • Biphenyl Compounds
  • Diabetes Mellitus, Type 1 / complications
  • Diabetic Retinopathy / drug therapy*
  • Diabetic Retinopathy / etiology
  • Double-Blind Method
  • Dry Eye Syndromes / drug therapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Ophthalmic Solutions / administration & dosage
  • Surveys and Questionnaires
  • Tetrazoles / therapeutic use*

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Benzimidazoles
  • Biphenyl Compounds
  • Ophthalmic Solutions
  • Tetrazoles
  • candesartan